136563-60-5

Upstream product

• 104-83-6 1-Chloro-4-(chloromethyl)benzene 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 56441-54-4 4-ethoxycarbonylphenoxy-(4'-chlorophenyl)-methane 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 136563-59-2 4-(4-Chloro-benzyloxy)-benzoic acid hydrazide 

Downstream Products

• 1630012-71-3 C₁₉H₂₂ClN₃O₃ 
• 1630013-19-2 4-butyl-5-(4-(4-chlorobenzyloxy)phenyl)-2H-1,2,4-triazole-3(4H)-one 

Relevant academic research and scientific papers

Synthesis and anticonvulsant activity evaluation of 4-butyl-5-(4- alkoxyphenyl)-2H-1,2,4-triazole-3(4H)-ones

A series of 4-butyl-5-(4-alkoxyphenyl)-2H-1,2,4-triazole-3(4H)-ones (6a-6u) was designed and synthesized. The anticonvulsant effects and neurotoxicity of the compounds were evaluated with maximal electroshock test and rotarod test. Among the synthetic compounds, 4-butyl-5-(4-(2-fluorinebenzyl)phenyl)-2H-1,2,4- triazole-3 (4H)-one (6k) was the most potent with ED50 value of 27.4 mg/kg and protective index (PI = TD50/ED50) value of 12.0. Besides the anti-MES efficacy, the potency of compound 6k against seizures induced by pentylenetetrazole (PTZ), 3-mercaptopropionic acid (3-MP), and bicuculline (BIC) was also established, which suggested that the mechanisms of action including enhancing of GABAergic activity might be involved in its anticonvulsant activity.